Page contentsPage contents Key facts Decision Key facts Active substance iloperidone Therapeutic area Psychiatry Decision number P/71/2011 PIP number EMEA-000995-PIP01-10 Pharmaceutical form(s) Suspension for injectionTablet Condition(s) / indication(s) Treatment of schizophrenia Route(s) of administration Intramuscular useOral use Contact for public enquiries Vanda Pharmaceuticals Ltd United StatesE-mail: gunther.birznieks@vandapharma.comTel. +1 202 7343416Fax +1 202 2961450 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 04/04/2011 Compliance check done No Decision P/71/2011: EMA decision of 4 April 2011 on the granting of a product specific waiver for iloperidone (EMEA-000995-PIP01-10)Adopted Reference Number: EMA/221083/2011 English (EN) (65.92 KB - PDF)First published: 10/05/2011 Last updated: 10/05/2011 View Share this page